Home » Biolaxy Secures IND Approval for Oral Insulin
Biolaxy Secures IND Approval for Oral Insulin
Shanghai Biolaxy announced the Chinese State Food & Drug Administration has approved
the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes.
San Francisco Business Journal
San Francisco Business Journal
Upcoming Events
-
07May
-
14May
-
30May